Antibiotic prophylaxis in an animal model of chronic peritoneal exposure

Peritoneal Dialysis International

Volumn 26, Issue 2, 2006, Pages 249-258

  Choi, Jaehwa ^a   Credit, Kimberly ^a   Henderson, Karla ^a   Deverkadra, Ravi ^a   Vanpelt, Heather M ^a   He, Zhi ^a   Flessner, Michael F ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Angiogenesis; Animal model; Antibiotics; Fibrosis; Peritoneal transport; Peritonitis

Indexed keywords

ANTIBIOTIC AGENT; BICARBONATE; CD31 ANTIGEN; CEFAZOLIN; COLLAGEN; DIALYSIS FLUID; GENTAMICIN; GLUCOSE; GLYCOSAMINOGLYCAN POLYSULFATE; HYALURONIC ACID; RINGER SOLUTION;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIAL INFECTION; BACTERIUM CULTURE; CHRONICITY; CONTROLLED STUDY; FEMALE; FILTRATION; IMAGE ANALYSIS; INFECTION RATE; NONHUMAN; PERITONEAL CATHETER; PERITONEAL DIALYSIS; PERITONEAL FLUID; PERITONITIS; PRIORITY JOURNAL; PROTEIN TRANSPORT; RAT; RAT STRAIN; SOLUTE; ANIMAL; DISEASE MODEL; SPRAGUE DAWLEY RAT;

ANIMALS; ANTIBIOTIC PROPHYLAXIS; BACTERIAL INFECTIONS; DISEASE MODELS, ANIMAL; FEMALE; PERITONEAL DIALYSIS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 33747122421     PISSN: 08968608     EISSN: None     Source Type: Journal    
DOI: 10.1177/089686080602600222     Document Type: Article

References (47)

1. Vanholder R, van Biesen W. Incidence of infectious morbidity and mortality in dialysis patients. Blood Purif 2002; 20:477-80.
2. Woodrow G, Turney JH, Brownjohn AM. Technique failure in peritoneal dialysis and its impact on patient survival. Perit Dial Int 1997; 17:360-4.
3. Troidle L, Gorban-Brennan N, Kliger A, Finkelstein FO. Continuous peritoneal dialysis-associated peritonitis: a review and current concepts. Semin Dial 2003; 16:428-37.
4. Albrektsen GE, Wideroe TE, Nilsen TI, Romundstad P. Radtke M, Hallan S, et al. Transperitoneal water transport before, during, and after episodes with infectious peritonitis in patients treated with CAPD. Am J Kidney Dis 2004; 43:485-91.
5. Chen JR. Pan HH, Lee CH, Chien YS, Lee CT, Liu TT, et al. loLgitudinal change in peritoneal membrane function with continuous ambulatory peritoneal dialysis (CAPD) after peritonitis episodes. Chang Gung Med J 2004; 27: 29-34.
6. Smit W, van den Berg N, Schouten N, Aikens F, Struijk DG, Krediet RT. Free-water transport in fast transport status: a comparison between CAPD peritonitis and long-term PD. Kidney Int 2004; 65:298-303.
7. Ni J, Moulin P, Gianello P, Feron O, Balligand JL, Devuyst O. Mice that lack endothelial nitric oxide synthase are protected against functional and structural modifications induced by acute peritonitis. J Am Soc Nephrol 2003; 14: 3205-16.
8. Williams JD, Craig KJ, Topley N, von Ruhland C, Fallon M, Newman GR, et al. Morphologic changesin the peritoneal membrane of patients with renal disease. J Am Soc Nephrol 2002; 13:470-9.
9. Williams JD, Craig KJ, von Ruhland C, Topley N, Williams GT. The natural course of peritoneal membrane biology during peritoneal dialysis. Kidney Int Suppl 2003; 88: S43-9.
10. Devuyst O, Topley N, Williams JD. Morphological and functional changes in the dialysed peritoneal cavity: impact of more biocompatible solutions. Nephrol Dial Transplant 2002; 17(Suppl 3):12-15.
11. Williams JD, Craig KJ, Toptey N, Williams GT. Peritoneal dialysis: changes to the structure ofthe peritoneal membrane and potential for biocompatible solutions. Kidney Int Suppl 2003; 84:S158-61.
12. Mortier S, De Vriese AS, Leyssens A, Vanacker NJ, Faict D, Cornelissen M, et al. Antibiotic administration in an animal model of chronic peritoneal dialysate exposure. Perit Dial Int 2003; 23:331-8.
13. De Vriese AS, Mortier S, Cornelissen M, Palmans E, Vanacker NJ, Leyssens A, et al. The effects of heparin administration in an animal model of chronic peritoneal dialysate exposure. Perit Dial Int 2002; 22:566-72.
14. Flessner MF, Schwab A. Pressure threshold for fluid loss from the peritoneal cavity. Am J Physial 1996; 270: F377-F390.
15. Twardowski ZJ, Prowant BF, Nolph KD, Martinez AJ, Lampton LM. High volume, low frequency continuous ambulatory peritoneal dialysis. Kidney Int 1983; 23: 64-70.
16. Flessner MF. Small-solute transport across specific peritoneal tissue surfaces in the rat. J Am Soc Nephrol 1996; 7:225-33.
17. Flessner MF. In vivo peritonealchamber: linking structure and transport function. Perit Dial Int 2001; 21(Suppl 3): S335-7.
18. Hasan J, Byers R, Jayson GC. Intra-tumoural microvessel density in human solid tumours. Br J Cancer 2002; 86: 1566-77.
19. Vermeulen PB, Gasparini G, Fox SB, Toi M, Martin L, McCulloch P, et al. Quantification ofangiogenesisin solid human tumours: an international consensus on the methodology and criteria of evaluation. Eur J Cancer 1996; 32A: 2474-84.
20. Reddy GK, Enwemeka CS. A simplified method for the analysis of hydroxyproline in biological tissues. Clin Biochem 1996; 29:225-9.
21. Hekking LH, Aalders MC, van Gelderop E, Zweers MM, Struijk DG, Havenith CE, et al. Effect of peritoneal dialysis fluid measured in viva in a rat-model of continuous peritoneal dialysis. Adv Perit Dial 1998; 14:14-18.
22. Wieczorowska-Tobis K, Korybalska K, Polubinska A, Radkowski M, Breborowicz A, Oreopoulos DG. In vivo model to study the biocompatibility of peritoneal dialysis solutions. Int J Artif Organs 1997; 20:673-7.
23. ter Wee PM, Beelen RH, van den Born J. The application of animal models to study the biocompatibility of bicarbonate-buffered peritoneal dialysis solutions. Kidney Int Suppl 2003; 88:575-83.
24. van Biesen W, Veys N, Vanholder R, Lameire N. New concepts in peritoneal dialysis: new wine in old barrels? Artif Organs 2003; 27:398-405.
25. Peng WX, Guo QY, Liu SM, Liu CZ, Lindholm B, Wang T. Comparison of three chronic dialysis models. Adv Perit Dial 2000; 16:51-4.
26. Gorman SP, Jones DS, Mawhinney WM, McGovern JG, Adair CG. Conditioning fluid influences on the surface properties of silicone and polyurethane peritoneat catheters: implications for infection. J Mater Sci Mater Med 1997; 8:631-5.
27. Swartz R, Messana J, Holmes C, Williams J. Biofilm formation on peritoneal catheters does not require the presence of infection. ASAIO Trans 1991; 37:626-34.
28. Marrie TJ, Noble MA, Costerton JW. Examination of the morphology of bacteria adhering to peritoneal dialysis catheters by scanning and transmission electron microscopy. J Clin Microbiol 1983; 18:1388-98.
29. Kim DK, Yoo TH, Ryu DR, Xu ZG, Kim HJ, Choi KH, et al. Changes in causative organisms and their antimicrobial susceptibilities in CAPD peritonitis: a single center's experience over one decade. Perit Dial Int 2004; 24:424-32.
30. Fernandez MA, Ortiz AM, Valenzuela M, Morales RA. peritoneal dialysis in chronic renal failure patients over 65 years of age. Adv Perit Dial 2004; 20:128-31.
31. Nakamoto H, Hashikita Y, Itabashi A, Kobayashi T, Suzuki H. Changes in the organisms of resistant peritonitis in patients on continuous ambulatory peritoneat dialysis. Adv Penit Dial 2004; 20:52-7.
32. Strijack C, Harding GK, Ariano RE, Zelenitsky SA. Peritoneal fluid titer test for peritonea l dialysis-related peritonitis. Antimicrob Agents Chemother 2004; 48:1719-26.
33. Musi B, Braide M, Carlsson O, Wieslander A, Albrektsson A, Ketteter M, et al. Biocompatibility of peritoneat dialysis fluids: long-term exposure of nonuremicrats. Perit Dial Int 2004; 24:37-47.
34. Mortier S, Faict D, Schalkwijk CG, Lameire NH, De Vniese AS. Long-term exposure to new peritoneal dialysis solutions: effects on the peritoneal membrane. Kidney Int 2004; 66:1257-65.
35. Margetts PJ, Gyorffy S, Kolb M, Yu L, Hoff CM, Holmes CJ, et al. Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 2002; 13:721-8.
36. Matsuki T, Duting BR. TN F-alpha modulates arteriotar reactivity secondary to a change in intimal permeability. Microcirculation 2000; 7:411-18.
37. Henry CB, Duling BR. TNF-alpha increases entry of macromolecules into luminal endothelial cell glycocalyx. Am J Physiol Heart Circ Physiol 2000; 279: H2815-H2823.
38. Wang T, Heimburger O, Qureshi AR, Waniewski J, Bergstrom J, Lindholm B. Physiological saline is not a biocompatible peritoneal dialysis solution. Int J Artif Organs 1999; 22:88-93.
39. Styszynski A, Podkowka R, Wieczorowska-Tobis K, Kwiatkowska B, Ksiazek K, Breborowicz A, et al. Glucose suppresses penitoneat inflammatory reactions and mesothelial hyperptasia caused by intrapenitoneal saline infusion. Adv Penit Dial 2002; 18:21-5.
40. Wieczorowska-Tobis K, Styszynski A, Polubinska A, Radkowski M, Breborowicz A, Oreopoulos DG. Hypertonicity of dialysis fluid suppresses intraperitoneal inflammation. Adv Petit Dial 2000; 16:262-6.
41. Flessner MF. The role of extracellular matrix in transperitoneal transport of water andsolutes. Perit Dial Int 2001; 21(Suppl 3):524-9.
42. Flessner MF. Changes in the peritoneal interstitium and their effect on peritoneat transport. Perit Dial Int 1999; 19(Suppt 2):S77-82.
43. Breborowicz A, Wieczorowska K, Knapowski J, Martis L, Serkes KB, Oreopoutos DG. Chondroitin sulphate and peritoneal permeability. Adv Perit Dial 1992; 8:11-14.
44. Flessner MF, Fenstermacher JD, Dedrick RL, Blasberg RG. A distributed model of peritoneal-plasma transport: tissue concentration gradients. Am J Physiol 1985; 248: F425-F435.
45. van Westrhenen R, de Waart DR, Akman S, Krediet RI. Assessment of peritoneat fibrosis by conventional light microscopy and hydroxyproline measurements. Petit Dial Int 2004; 24:290-2.
46. Be Vriese AS, Flyvbjerg A, Mortier S. Litton RG, Lameire NH. Inhibition of the interaction of AGE-RAGE prevents hyperglycemia-induced fibrosis of the peritoneal membrane. J Am Soc Nephnol 2003; 14:2109-18.
47. Flessner MF, Lofthouse J, Williams A. Chronic alteration of subperitoneal tissue and peritoneat transport. Adv Perit Dial 2002; 18:12-14.